1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial. Issue 4 (April 2021) Authors: Bellmunt, Joaquim; Hussain, Maha; Gschwend, Jürgen E; Albers, Peter; Oudard, Stephane; Castellano, Daniel; Daneshmand, Siamak; Nishiyama, Hiroyuki; Majchrowicz, Martin; Degaonkar, Viraj; Shi, Yi; Mariathasan, Sanjeev; Grivas, Petros; Drakaki, Alexandra; O'Donnell, Peter H; Rosenberg, Jonathan E; ... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer. (23rd October 2020) Authors: Joshi, Monika; Grivas, Petros; Mortazavi, Amir; Monk, Paul; Clinton, Steven K.; Sue‐Ann Woo, Michele; Holder, Sheldon L.; Drabick, Joseph J.; Yin, Ming Journal: Cancer medicine Issue: Volume 9:Number 24(2020) Page Start: 9365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer. (25th October 2021) Authors: Makrakis, Dimitrios; Talukder, Rafee; Diamantopoulos, Leonidas N.; Carril‐Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Koshkin, Vadim S.; Park, Joseph J.; Alva, Ajjai; Bilen, Mehmet A.; Stewart, Tyler F.; McKay, Rana R.; Santos, Victor S.; Agarwal, Neeraj; Jain, Jayanshu; Zakharia, Yo... Journal: BJU international Issue: Volume 130:Number 5(2022) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Issue 10031 (7th May 2016) Authors: Rosenberg, Jonathan E; Hoffman-Censits, Jean; Powles, Tom; van der Heijden, Michiel S; Balar, Arjun V; Necchi, Andrea; Dawson, Nancy; O'Donnell, Peter H; Balmanoukian, Ani; Loriot, Yohann; Srinivas, Sandy; Retz, Margitta M; Grivas, Petros; Joseph, Richard W; Galsky, Matthew D; Fleming, Mark T; Pe... Journal: Lancet Issue: Volume 387:Issue 10031(2016) Page Start: 1909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice. (June 2021) Authors: Grivas, Petros; Agarwal, Neeraj; Pal, Sumanta; Kalebasty, Arash Rezazadeh; Sridhar, Srikala S.; Smith, Jodi; Devgan, Geeta; Sternberg, Cora N.; Bellmunt, Joaquim Journal: Cancer treatment reviews Issue: Volume 97(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cancer and COVID-19 – Authors' reply. Issue 10257 (10th October 2020) Authors: Kuderer, Nicole M; Wulff-Burchfield, Elizabeth; Rubinstein, Samuel M; Grivas, Petros; Warner, Jeremy L Journal: Lancet Issue: Volume 396:Issue 10257(2020) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Challenges faced when identifying patients for combination immunotherapy. (August 2017) Authors: Ernstoff, Marc S; Gandhi, Shipra; Pandey, Manu; Puzanov, Igor; Grivas, Petros; Montero, Alberto; Velcheti, Vamsidhar; Turk, Mary Jo; Diaz-Montero, Claudia Marcela; Lewis, Lionel D; Morrison, Carl Journal: Future oncology Issue: Volume 13:Number 18(2017) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗